Gudang Garam Tbk PT
IDX:GGRM
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
EV/FCFF
Enterprise Value to Free Cash Flow to Firm (EV/FCFF) ratio compares a company`s total enterprise value to the free cash flow available to all investors, both debt and equity holders. It shows how much investors are paying for each dollar of cash flow the business generates before interest payments.
Enterprise Value to Free Cash Flow to Firm (EV/FCFF) ratio compares a company`s total enterprise value to the free cash flow available to all investors, both debt and equity holders. It shows how much investors are paying for each dollar of cash flow the business generates before interest payments.
Valuation Scenarios
If EV/FCFF returns to its 3-Year Average (7.5), the stock would be worth Rp39 131.05 (142% upside from current price).
| Scenario | EV/FCFF Value | Implied Price | Upside/Downside |
|---|---|---|---|
| Current Multiple | 3.1 | Rp16 175 |
0%
|
| 3-Year Average | 7.5 | Rp39 131.05 |
+142%
|
| 5-Year Average | 7.8 | Rp40 652.28 |
+151%
|
| Industry Average | 7.6 | Rp39 922.01 |
+147%
|
| Country Average | 9.6 | Rp49 998.15 |
+209%
|
Forward EV/FCFF
Today’s price vs future free cash flow to firm
Peer Comparison
| Market Cap | EV/FCFF | P/E | ||||
|---|---|---|---|---|---|---|
| ID |
|
Gudang Garam Tbk PT
IDX:GGRM
|
31.1T IDR | 3.1 | 20 | |
| US |
|
Philip Morris International Inc
NYSE:PM
|
258.2B USD | 28 | 22.8 | |
| UK |
|
British American Tobacco PLC
LSE:BATS
|
94.7B GBP | 22.4 | 12.2 | |
| US |
|
Altria Group Inc
NYSE:MO
|
113.5B USD | 14.6 | 16.4 | |
| JP |
|
Japan Tobacco Inc
TSE:2914
|
10.3T JPY | 30.9 | 20.1 | |
| IN |
|
ITC Ltd
NSE:ITC
|
3.8T INR | 23.7 | 11.3 | |
| UK |
|
Imperial Brands PLC
LSE:IMB
|
22.4B GBP | 9.2 | 10.9 | |
| SE |
S
|
Swedish Match AB
F:SWMC
|
15.2B EUR | 32.6 | 25.4 | |
| KR |
|
KT&G Corp
KRX:033780
|
18.5T KRW | -190.8 | 16.9 | |
| CN |
|
Smoore International Holdings Ltd
HKEX:6969
|
57.7B HKD | 57.3 | 47.3 | |
| ID |
|
Hanjaya Mandala Sampoerna Tbk PT
IDX:HMSP
|
90.1T IDR | 12.9 | 13.6 |
Market Distribution
| Min | 0 |
| 30th Percentile | 5.7 |
| Median | 9.6 |
| 70th Percentile | 18 |
| Max | 1 364 898.3 |
Other Multiples
Gudang Garam Tbk PT
Glance View
Gudang Garam Tbk PT, a prominent name in Indonesia's tobacco industry, traces its roots back to 1958, founded by the visionary Surya Wonowidjojo in the bustling city of Kediri, East Java. The company has grown to become one of the leading manufacturers of kretek, a unique blend of tobacco and clove cigarettes that is deeply embedded in the cultural fabric of Indonesia. The craft of making these aromatic cigarettes involves a meticulous process of selecting and blending high-quality tobacco with distinct Indonesian cloves, a key differentiator that caters to local tastes. This meticulous production system underscores the company’s commitment to quality, ensuring its products remain competitive in an industry dominated by tradition as well as innovation. Financially, Gudang Garam’s success is built largely on its robust distribution network and its ability to scale operations efficiently. The company has harnessed the power of this network not only across Indonesia but also in certain international markets where there is a demand for kretek. By strategically positioning itself as a premium brand through extensive marketing and brand positioning, Gudang Garam maintains a loyal consumer base. This has allowed the company to capitalize on its brand prestige and generate significant revenue from its core products. Meanwhile, despite operating in a heavily regulated industry with growing health concerns, Gudang Garam has demonstrated resilience by continuously innovating its product line to adapt to consumer preferences and regulatory landscapes, ensuring its enduring presence in the market.